Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue
Patrick Chêne(Novartis (Switzerland)), Thomas Radimerski(Novartis (Switzerland))
Cited by 81
Related Papers
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
|Breast Cancer Research|2008|224
Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ
|Protein Science|2017|69
Bim and Mcl-1 exert key roles in regulating JAK2V617Fcell survival
|BMC Cancer|2011|25